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Data independent analysis (DIA) exemplified by sequential window acquisition of all theoretical mass 
spectra (SWATH-MS) provides robust quantitative proteomics data, but the lack of a public primary 
human T-cell spectral library is a current resource gap. Here, we report the generation of a high-quality 
spectral library containing data for 4,833 distinct proteins from human T-cells across genetically 
unrelated donors, covering ~24% proteins of the UniProt/SwissProt reviewed human proteome. 
SWATH-MS analysis of 18 primary T-cell samples using the new human T-cell spectral library reliably 
identified and quantified 2,850 proteins at 1% false discovery rate (FDR). In comparison, the larger 
Pan-human spectral library identified and quantified 2,794 T-cell proteins in the same dataset. As the 
libraries identified an overlapping set of proteins, combining the two libraries resulted in quantification 
of 4,078 human T-cell proteins. Collectively, this large data archive will be a useful public resource for 
human T-cell proteomic studies. The human T-cell library is available at SWATHAtlas and the data are 
available via ProteomeXchange (PXD019446 and PXD019542) and PeptideAtlas (PASS01587).
Background & Summary
T-cells are the central regulators of adaptive immunity and among the most diverse cellular compartment in 
human physiology1. While advanced transcriptomics, including single cell transcriptomics, is commonly applied 
to investigate T-cell subsets to infer T-cell function, post-translational modifications (PTMs), splice variants and 
other downstream modifications regularly occur and must not be overlooked. Accordingly, quantitative T-cell 
proteomics is an essential tool in understanding the workings of T-cells in health and disease1–3. Nanoscale liquid 
chromatography-coupled tandem mass spectrometry (LC-MS/MS) has become a standard technique for quanti-
tative proteomic studies in human biology and disease, by which traditional data dependent acquisition (DDA) 
mass spectrometry (MS) proteomics has added significant understanding to the immunological process4–6. 
The stochastic selection of precursor ions has led to large proportion of missing data, which impacts down-
stream statistical analyses in proteomics annotation, functional interpretation and therapeutic development7,8. 
To overcome these limitations, data-independent acquisition (DIA-MS) was performed to acquire all ions by 
dividing ion space. The introduction of the sequential window acquisition of all theoretical fragment ion spectra 
(SWATH-MS) which is a combination of tandem mass spectrometry performed by quadrupole time-of-flight 
(QTof) instruments, DIA-MS and a peptide-centric data query method, facilitated the reproducible quantifi-
cation of proteomes to perform high-throughput analysis of immunological samples9. This technique is now 
standardized to obtain highly reproducible data in international laboratories10.
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Despite broad adoption of SWATH-MS, its application in the field of immunology has been limited, partly 
due to the absence of publicly available comprehensive spectral libraries for the hundreds of immune cell subsets 
defined11. A Pan-human spectral library covering ~10,000 proteins was reported by Rosenberger et al. in 201412, 
which unfortunately did not include primary human T-cells. Given the role T-cells play in the regulation of 
immune compartments, tissues, organs and the general homeostasis of human biology1, having a high-quality 
publicly available spectral library of natural human T-cell proteins will reduce resources, time, sample and anal-
ysis for future experiments.
To address this important gap in knowledge, we generated a comprehensive spectral library of primary human 
T-cells from four genetically unrelated individuals in ex vivo and in vitro stimulated states. The samples were 
obtained through off-gel fractionation of tryptic digested protein samples. Collectively, a total of 96 samples were 
analyzed to generate the primary human T-cell spectral library. Using the above described techniques, we could 
identify more than 4,800 unique proteins. In an experiment to test the performance of the library on SWATH-MS, 
we reliably identified and quantified 2,850 proteins across 18 primary human T-cell samples. Further, we per-
formed a direct comparison of our purified human T-cell spectral library performance against the Pan-human 
spectral library which showed only 38% overlap. The combination of the data from two libraries data sources 
produced 4,078 proteins, which will provide a useful bassline for future T-cell proteomic investigations. Further, 
to identify the strengths and weaknesses of SWATH-MS compared with traditional DDA-MS based shotgun 
proteomic method for T-cell proteomics, we compared the label free DDA-MS data acquired on the same set of 
samples with SWATH-MS data. We identified an improved performance in SWATH-MS in terms of number of 
quantified proteins and data reproducibility.
Methods
Building a primary human T-cell spectral library. Human T-cell isolation, activation and phenotyp-
ing. Ethics approval was obtained from the human research ethics committee QIMR Berghofer, Brisbane, 
Queensland, Australia (HREC #P2058). Written informed consent was obtained from all volunteers. Peripheral 
blood mononuclear cells (PBMCs) were separated from buffy coats obtained from Red Cross Blood Bank, 
Australia using a Ficoll-Paque Plus (GE Healthcare, USA) gradient centrifugation. These cells were sorted using 
pan human T-cell magnetic beads (Miltenyi Biotec, Germany) to obtain primary human T-cells with over > 95% 
purity as confirmed by flow cytometry. Using the separated PBMCs, we prepared one in vitro (SpLib_1) activated 
and three ex vivo (SpLib_2, SpLib_3 and SpLib_4) CD3+ T-cell samples. CD3/28 Dynabeads (Thermo Fisher, 
USA) at 1:1 cell to bead ratio in RPMI 1640 medium, 10% foetal calf serum (Gibco, USA) and 50 units/ml peni-
cillin and 50 μg/ml streptomycin (Gibco, USA) to activate CD3+ T-cells. These cells were cultured over 7 days at 
37 °C in a humidified, 5% CO2 incubator. To validate T-cell purity, enriched cells were stained with LIVE/DEAD 
Fixable Aqua (Life Technologies, USA), CD3-APC-eFluor780 (eBioscience, USA) and a dump panel including 
CD14+ Pacific Blue (BioLegend, USA), CD16-Pacific Blue (BioLegend, USA), and CD19-Pacific Blue (BioLegend, 
USA). Only live single cells (excluding doublets) were gated and run on a LSR Fortessa 4 (BD Biosciences, USA). 
Flow cytometry data was analyzed using FlowJo version 10 (TreeStar, USA).
Proteomic sample preparation. The workflow for primary human T-cell spectral library generation is summa-
rized in Fig. 1. T-cells isolated for the spectral library generation were lysed in 100 µL of buffer composed of 
100 mM TEAB (Triethylammonium bicarbonate) (Sigma, USA), 1% sodium dodecyl sulfate (SDS) (Bio-Rad lab-
oratories, USA), 5 mM MgCl2 (Sigma, USA) supplemented with 1x Roche complete protease inhibitors (Sigma, 
USA). Immediately after the lysis, ultrapure benzonase (Sigma, USA) in 50 µL of 50 mM Tris, 2 µL of 20 mM NaCl 
and 2 mM MgCl2 at 1 unit/µl concentration was added to degrade DNA and RNA. The samples were incubated at 
4 °C for 45 minutes with constant agitation and the protein concentration was determined using the Pierce BCA 
assay kit (Thermo Fisher Scientific, USA) following the manufacturer’s protocol. An aliquot of ~600 μg of protein 
was reduced in 20 mM dithiothreitol (DTT) (Sigma, USA) at 75 °C for 10 minutes. After cooling the sample for 
~10 minutes at room temperature, 0.5 M 2-iodoacetamide (IAA) (Sigma, USA) was added for a final concentra-
tion of 40 mM, and kept for 30 minutes in the dark at room temperature to alkylate proteins. Detergent removal 
was performed by the filter aided sample preparation method13 using 10 mL, 10 KDa Amicon molecular weight 
cutoff filter tubes (Merk Millipore, USA). First, the tube was equilibrated by spinning 600 µL of 100 mM TEAB at 
3,100 × g for 10 minutes in a 5810 R Eppendorf centrifuge (Eppendorf, Germany). Second, the protein sample was 
mixed with six volume of freshly prepared 8 M urea (Sigma, USA) in 100 mM TEAB, 10% isopropanol (Sigma, 
USA) and transferred to the filter unit and spun at 3,100 × g for 30 minutes. Third, detergents were removed 
using buffer exchange in which the protein mixture was washed with 500 µL of 8 M urea in 100 mM TEAB, 10% 
(v/v) isopropanol. This was followed by another wash with 500 µL of 100 mM TEAB, 10% isopropanol and then 
two washes with 500 µL of 50 mM TEAB. In all the washes, samples were spun at 3,100 × g for 30 minutes to 
remove the detergents. The concentrated protein solution was then collected from the filter unit and transferred 
to an Eppendorf microcentrifuge tube (Eppendorf, Germany) to perform the protein digestion. Sequencing grade 
modified trypsin (Sigma, USA) at protein to trypsin ratio of 50:1 was added and incubated overnight at 37 °C in 
a humidified incubator. The resulting peptides were desalted using a Sep-Pak Vac C18 cartridge (Waters, USA), 
lyophilized with a speed vacuum prior to fractionation in Agilent 3100 off-gel fractionator (Agilent technologies, 
USA) using a 24 cm, pH 3–10 IPG strip (GE Health Care, USA) according to the manufacturer’s protocol. During 
fractionation, a maximum current of 50 µA until 50 kV/h was used. Each fraction was lyophilized and then resus-
pended in 30 µL of MS grade water with 2% acetonitrile (Sigma, USA), 0.1% formic acid (v/v) (Sigma, USA) prior 
to LC-MS/MS analysis.
DDA-MS data acquisition. Peptide samples resuspended in 30 µL of MS grade water with 2% acetonitrile, 0.1% 
formic acid (v/v) were spiked with the indexed retention time (iRT) peptides (1:100) (Biognosys, Switzerland). To 
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chromatographically separate the peptide samples, we used either Eksigent cHiPLCTM-nanoflex (For SpLib_1, 
SpLib_1 and SpLib_3) or Eksigent Nano Ultra 1D + (SpLib_4) systems (SCIEX, USA), where 10 uL of each sam-
ples was injected to a 15 cm long ChromXP C18-CL column (particle size 3 µm, 120 Å, 150 mm × 0.075 mm). A 
pre-concentration step (10 minutes) was performed employing a ChromXP trap column (C18-CL, 5 µm, 120 Å, 
0.3 × 10 mm) before commencement of the gradient. A flow rate of 500 nL/minute was used to generate SPLib_1, 
SPLib_2 and SPLib_3, while 250 nL/minute flow rate was used for SPLib_4. The mobile phase consisted of solvent 
A (0.1% formic acid/H2O) and solvent B (100 acetonitrile/0.1% formic acid) was used for the three consecutive 
linear gradients for peptide elution: 5–10% solvent B (acetonitrile/0.1% formic acid) over 2 minutes, 10–40% 
solvent B over 58 minutes and 40–50% solvent B over 5 minutes. A final gradient from 50% to 95% solvent B in 
10 minutes was used to clean the column. Eluates from the column were directly injected into the NanoSpray II 
ionization source of a TripleTOF 5600 MS/MS System (SCIEX, USA) operated in positive ion electrospray mode. 
The peptides and the DDA-MS acquisition protocol were created using Analyst 1.5.1 software (SCIEX, USA) 
in which a 300–2000 (m/z) precursor (MS) and 100–2000 (m/z) product (MS/MS) mass ranges were used. To 
acquire DDA-MS data for SPLib_1 to 3, we used 250 and 100 millisecond MS and MS/MS accumulation times 
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Fig. 1 Primary human T-cell spectral library generation workflow. Main steps used in (a) isolation of human 
peripheral blood mononuclear cells (PBMCs), purification of ex vivo CD3+ T-cells and in vitro activation 
(three ex vivo CD3+ T-cell samples and one in vitro activated CD3+ T-cell sample were obtained from PBMCs 
extracted from four different buffy coats). (b) Proteomic sample preparation, peptide fractionation and 
LC-MS/MS data acquisition. (c) Generation of individual spectral libraries for separate DDA-MS dataset. (d) 
Generation of a combined assay library compatible for multiple SWATH-MS data analysis platforms and quality 
control of assay libraries.
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respectively and the ions observed in the TOF-MS scan exceeding a threshold of 50 counts and a charge state 
of + 2 to + 4 were set to trigger the acquisition of MS spectra for a maximum of 10 most intense ions. DDA-MS 
data for SpLib_4 were acquired using 250 and 150 millisecond MS and MS/MS accumulation times respectively. 
Ions within the charge status of + 2 to + 5 were used to trigger the acquisition of MS spectra for a maximum of 
12 most intense ions.
Human T-cell spectral library generation. Acquired DDA-MS data was analysed through Trans-Proteomic 
Pipeline (TPP)14 to generate the primary human T-cell spectral library. In brief, after converting DDA-MS data 
into mzML file format (msConvert, ProteoWizard), each data set was searched using X!Tandem with k-score 
plugin and Comet against UniProtKB/Swiss-Prot human reviewed database (downloaded on 21.11.2017) with 
added decoy database and iRT sequence. Search parameters were set as; parent mass error of ± 50 ppm, fragment 
mass error of ± 0.05 Da, trypsin digestion allowing two missed cleavages while carbamidomethyl (57.021464@C) 
and oxidation (15.994915@M) were included as fixed and variable modifications respectively. Results were then 
scored and combined with PeptideProphet15 and iProphet16, respectively to proceed with the false discovery rate 
(FDR) calculation using MAYU17. Data filtered through the iProphet probability cut-off corresponding to pro-
tein FDR at 1% (Fig. 2a) as calculated by MAYU and spectraST18 were then used to generate individual spectral 
libraries normalised to iRT peptides. Then a consensus spectral library was built using the “Consensus” build 
action with “Union” join option in the SpectraST18. We used spectrast2tsv (msproteomicstools 0.8.0) to generate 
the final assay library compatible with SWATH-MS windows from 300–2000 m/z mass range and for different 
SWATH-MS data analysis platforms. DIALib-QC v1.1 was used to assess the quality of these spectral libraries and 
to validate for theoretical m/z values correctness of both precursor and fragments ions in the libraries19. Decoy 
sequences were added to OpenSWATH assay library using OpenSWATH decoy generator20.
Validation of the human T-cell spectral library. Isolation and activation of human CD4+ T-cells. We 
validated our human T-cell spectral library using a set of SWATH-MS and DDA-MS data generated from a time 
series T-cell proteomic experiment (Fig. 3a). CD3+ T-cells were isolated from PBMCs obtained from three volun-
teer blood donors following the procedure mentioned above. These cells were further purified using human CD4+ 
T-cell magnetic beads (Miltenyi Biotech, Germany) to obtain untouched CD4+ T-cells with over 95% purity, as 
assessed by flow cytometry. An aliquot from each donor was taken as ex vivo (0 hour) sample. The remaining 
purified cells from each donor were in vitro activated and cultured using the protocol above and harvested at 
6 hours, 12 hours, 24 hours, 3 days and 7 days of post activation. Collected cells were washed three times with PBS 
and the cell pellets stored at −80 °C for batch proteomics processing.
Preparation of samples for time series T-cell proteomic experiment. T-cell pellets obtained from time series 
experiment containing ~1 × 106 CD4+ T-cells were thawed on ice, and lysed in 2% SDS in 100 mM TEAB in 
the presence of protease inhibitor cocktail. After assessing the protein quantity using pierce BCA protein assay 
kit, ~20 μg from each cell lysate was separated for reduction (10 mM tris(2-carboxyethyl)phosphine/TCEP at 
60 °C for 30 minutes) and alkylation (40 mM 2-Chloroacetamide/2CAA at 37 °C in dark for 30 minutes). Protein 
co-precipitation with trypsin in cold (−20 °C) 100% methanol21 was used to obtain detergent free protein pel-
lets. These protein pellets were washed sequentially using 90% and 100% methanol and digested overnight with 
sequencing grade modified trypsin with final trypsin: protein ratio of 1:50 in 50 μl of 50 mM TEAB. StrataX C18 
solid phase extraction 1.3 mL columns (Phenomenex, USA) were used to desalt peptides and microBCA (Thermo 
Fisher scientific, USA) protein assay was used to quantify the peptide concentration.
Acquisition of SWATH-MS and DDA-MS data. Peptide samples were resuspended in 10 µL of MS grade water 
with 2% acetonitrile, 0.1% formic acid (v/v) and spiked with the indexed retention time (iRT) peptides (1:100). 
For SWATH-MS data acquisition, ~1 µg of peptides from each sample was injected at a flow rate of 250 nL/minute 
into Eksigent Nano Ultra 1D + system. A ChromXP C18-CL Trap column (C18-CL, 5 µm, 120 Å, 0.3 × 10 mm) 
and a ChromXP C18-CL column (particle size 3 µm, 120 Å, 150 mm × 0.075 mm) were used to separate peptides 
in the same chromatographic gradient described above. Using 100-variable window method, the eluted peptides 
were analyzed over 400–1250 m/z mass range by the same mass spectrometer to obtain the SWATH-MS data. 
Both MS and MS/MS data were accumulated over a period of 25 milliseconds at total cycle time of 2.572 seconds. 
The variable window method was generated according to the manufacturer’s instructions using Analyst 1.7 TF 
software (SCIEX, USA).
For DDA-MS data acquisition, ~1 μg of peptides from each sample was injected to ProteCol C18 trap column 
in Prominence Nano LC system (Shimadzu, Japan) to separate the ions in a ProteCol C18 (200 Å, 3 μm particle 
size, 150 mm × 150 μm) column at a flow rate of 1 μl/minute over 180 minutes linear gradient. The mobile phase 
consisted of solvent A (0.1% formic acid) and solvent B (100 acetonitrile/0.1% formic acid) was used for the three 
consecutive linear gradients for peptide elution: 5–10% solvent B (acetonitrile/0.1% formic acid) over 5 minutes, 
10–27% solvent B over 147 minutes and 27–40% solvent B over 10 minutes. A final gradient from 40% to 95% 
solvent B in 10 minute was used to clean the column. The Nano LC system was operated with the Chromeleon 
software (version 6.8, Dionex) embedded in Xcalibur software (version 3.0.63, Thermo Fisher Scientific, USA). 
Eluted peptides were ionized using Nano spray (Thermo Fisher Scientific, USA) ion source (ion spray voltage - 
1.75 V, heating temperature 285 °C). Peptide ions separated by Nano LC system were analyzed using a Velos Pro 
Orbitrap mass spectrometer (Thermo Fisher Scientific, USA). In DDA-MS, the MS was controlled and operated 
using the Xcalibur software to obtain MS and MS/MS spectral data for maximum of 15 peptide ions with charge 
status between +2 to +4 at 1.96 second window time. Collision-induced dissociation mode was used to fragment 
the peptides in the ion trap.
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SWATH-MS data analysis. PeakView v2.2.0 (SCIEX, USA) with the SWATH-MS acquisition MicroApp 
2.0.1.2133 was used to extract SWATH-MS peak areas. Ion library parameters were set with 6 peptides per pro-
tein, 6 transitions per peptides, peptide confidence threshold of 99% and FDR threshold of 1%. The time window 
and width were set to 3 minute and 75 ppm, respectively in XIC manager. The data were analysed separately 
against both primary human T-cell spectral library and Pan-human spectral library reported by Rosenberger et al. 
in 201422. In the PeakView analysis, retention times for all SWATH-MS experiments were auto-recalibrated based 
on iRT peptide retention times. Quantitation table files for fragment ions, peptides and proteins were generated 
using PeakView and MarkerView v1.2.1.1 (SCIEX, USA) and the peptides quantified with peak areas of minimum 
two fragment ions were selected to obtain the area under the curves of peptides to calculate the relative intensities 
of proteins for normalization and differential expression (DE) analysis.
a







































0 20 40 60 80 100
CD28 signaling in T-helper cells
Integrin signaling





NFAT in regulation of the immune response
Regulation of IL-2 in activated and anergic T-cells
CTLA4 signaling in cytotoxic T-cells
iCOS-iCOSL signaling in T-helper cells
Leukocyte extravasation signaling





NF-kB activation by viruses
4-1BB signaling in T-cells






















Fig. 2 Statistics of the primary human T-cell spectral library. (a) Statistics of individual spectral libraries used 
in the generation of human T-cell spectral library. (b) Protein, peptide and peptide spectral matches (PSMs) 
of individual libraries as function of protein FDR. (c) Venn diagram depicting the protein overlaps between 
different spectral libraries. (d) Frequency distribution of peptides of different lengths in human T-cell spectral 
library. (e) Frequency distribution of proteins with different peptide numbers in human T-cell spectral library. 
(f) First 30 significant immune related canonical pathways represented by the T-cell spectral library (Core 
analysis, Ingenuity pathway analysis, Qiagen Bioinformatics, USA) (g) Protein coverage of the human T-cell 
spectral library for T-cell receptor (TCR) signaling pathways. Proteins highlighted in pink are included in 
human T-cell spectral library. (SpLib_1 - in vitro activated human T-cell spectral library, SpLib_2, 3 and 4 - ex 
vivo human T-cell spectral libraries).
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DDA-MS data analysis. DDA-MS data were analyzed against UniProtKB/Swiss-Prot reviewed human proteome 
database using MaxQuant (Release 1.6.0.16) software23. In the analysis, precursor and product mass tolerance 
were set as ± 20 ppm and ± 40 ppm respectively to identify the peptides up to maximum charge of + 7 at one mis-
cleavage. Based on unique and razor peptide intensities, proteins at 1% FDR were quantified between runs which 
allowed the maximum number of peptide identifications.
Statistical analysis. Protein intensities across different samples were normalized using variance stabiliz-
ing normalization-global (VSNG, R language) method. Figures and statistical analysis were generated with R 
language and GraphPad Prism (version 8, GraphPad Software, USA) graphical package, and Microsoft Excel 
software packages (Microsoft, 2010). Analysis of pathway over-representation was performed using ingenu-
ity pathway core analysis (IPA, Qiagen Bioinformatics, USA). In MaxQuant analysis, proteins with multiple 
UniProtKB/SwissProt protein accessions and m-score less than 5 were excluded to increase the precision of the 
quantification data. Moreover, in both datasets, proteins which did not have intensity values for either >50% of 
the samples (n > 9) or two out of three replicates at a given time point were removed from the further analysis. 
Missing values in the remaining proteins were imputed using maximum likelihood algorithm (Bioconductor, R 
language). Differential expression of these proteins were calculated in terms of log2 fold change in which protein 
intensity data at each time point following activation were compared with that of ex vivo (0 h) value.
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Fig. 3 SWATH-MS data analysis against human T-cell and Pan human libraries and comparison with DDA-MS 
data. (a) Experimental protocol used to obtain human CD4+ T-cells at different in vitro activated status. Samples 
were obtained from three different donors. (b) Number of peptides and proteins detected by the analysis 
of CD4+ T-cells by SWATH-MS against human T-cell and pan-human spectral libraries and DDA-MS. (c) 
Proportional Venn diagram depicting the overlap between quantified SWATH-MS proteins against the two 
spectral libraries. (d) Proportional Venn diagram depicting the overlap between all the quantified SWATH-MS 
proteins and DDA-MS proteins. (e) Box plots showing the missing peptide intensity values in SWATH-MS 
and DDA-MS data (central lines and boxes represent means and 95% confidence intervals respectively while 
whiskers are 2.5 to 97.5 percentiles). (f) Distribution of Pearson correlation coefficient between protein 
expression data obtained by SWATH-MS and DDA-MS for human CD4+ T-cell time series experiment.
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Data Records
All the raw data (DDA), peak (mzML) and search result (pepXML) files24 used to generate the human T-cell spec-
tral library, and the consensus spectral library have been deposited in the ProteomeXchange Consortium through 
the PRIDE partner repository25. Primary human T-cell spectral library26 generated for different SWATH-MS data 
analysis platforms and their quality control reports generated through DIALib-QC v1.1 have been made available 
via the PeptideAtlas (SWATHAtlas) repository.
The raw data (SWATH-MS) files generated from the human CD4+ T-cell samples obtained at different activa-
tion stages, and PeakView search results and quantification data27 have been deposited in the ProteomeXchange 
Consortium through the PRIDE partner repository25.
technical Validation
Filtering high quality spectral data. To reduce false-positive identification, we used Mayu17 to calculate 
the FDR at protein level. We observed high quality spectral data as assessed by the number of total and true posi-
tive peptide spectral matches (PSMs), and the peptides and proteins detected as a function of protein FDR. In all 
four datasets, the number of identified proteins was saturated at 5% of protein FDR and the PSMs and peptides 
included in spectral libraries had FDRs considerably less than 1% (Fig. 2a,b).
Primary human T-cell spectral library for SWATH-MS. For SWATH-MS, we used four different sets 
of off-gel fractionated primary human T-cells to increase the proteins and peptide variability of the final spectral 
library. This resulted in detection of over 2,500 true positive proteins from each dataset filtered at 1% protein 
FDR and 2,022 proteins were common to all four libraries (Fig. 2c). Next, we combined all the individual spec-
tral libraries using spectrastST18, and used spectrast2tsv to generate the ‘Primary human T-cell spectral library’ 
containing 232,038 high quality transitions for 31,870 peptides of 4,833 distinct proteins. Over 45% of these 
proteins were identified with 5 or more peptides (Fig. 2d). Even though there were ~25% of the proteins identified 
with single peptide hits, high quality fragment ion spectra can be assured due to the selection of peptide spectral 
matches at 1% protein FDR (Fig. 2a). The number of amino acids in these peptides was varied between 7- 49 with 
mean of 13 (±4.48) (Fig. 2e). Moreover, we identified >50% of protein coverage for major immune pathways in 
IPA canonical pathways (Fig. 2e,f).
Comparison of SWATH-MS and DDA-MS data. Across the 18 samples, SWATH-MS data analysis 
against human T-cell library quantified 7,430 peptides (~27% of the peptides of the spectral library) including 6 
iRT peptides corresponding to 3,005 proteins (Fig. 3b) at 1% protein FDR. Quality control filtering to remove less 
reproducible proteins was resulted in accurate quantification of 2,850 proteins across 18 samples. Even though 
the Pan-human library comprised spectral data for larger number of peptides, the analysis resulted in less pep-
tide coverage compared to the human T-cell library, with only 4,156 peptides at 1% FDR corresponding to 2,794 
proteins (Fig. 3b). Interestingly, there was only 38% protein overlap between the SWATH-MS data obtained from 
two libraries (Fig. 3c). These overlapping, but two distinct groups of proteins were resulted in quantification 
of 4,078 proteins in CD4+ T-cells across 18 samples (Fig. 3c). Collectively, analysis of the SWATH-MS dataset 
against both libraries improved the number of quantified proteins detected by 45% and thus the two libraries can 
be considered as complementary.
In contrast to SWATH-MS, DDA-MS analysis quantified 3,531 proteins at 1% protein and peptide FDR. 
However, quality control filtering resulted in reduction to 2,562 high quality proteins. Only 262 new proteins 
were quantified by DDA-MS compared to the sum of proteins quantified by SWATH-MS (Fig. 3d). As expected, 
SWATH-MS returned less missing data compared to DDA-MS, particularly at the peptide level (Fig. 3e). Further, 
we calculated the correlation coefficient values between DE data of SWATH-MS and DDA-MS using Pearson’s 
correlation. Over ~70% of proteins showed a correlation coefficient over 0.3, indicating a considerably high con-
sistency between the two data acquisition methods (Fig. 3f). Importantly, SWATH-MS achieved an improved 
depth of protein quantification with half the LC-MS/MS run time which is a crucial factor in terms of cost and 
robustness of sample analysis.
Usage notes
While peptide samples for spectral library generation were prepared using filter aided sample preparation method 
in which trypsin was used for protein digestion, this library is suitable for accurate quantification of SWATH-MS 
data generated from the samples prepared from any other protein lysis protocols which uses trypsin, with/without 
LysC for complete digestion along with reduction and alkylation of cysteine bonds. This was exemplified by our 
use of a methanol co-precipitation procedure when preparing the time series human T-cell proteomic samples to 
validate the human T-cell spectral library.
Compatibility of spectral library to other LC-MS/MS settings. In this study, we used a TripleTOF 
5600 mass spectrometer and three consecutive linear gradients over 90 minute to acquire DDA-MS data for spec-
tral library generation. As the library contains spectral data for iRT peptides, retention times can be re-aligned 
and thus, can be used in analyzing the data acquired with different gradients28.
Code availability
A code used to generate the primary human T-cell SWATH spectral library building using the TPP is described 
in a recent publication14.
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